Last week, one of South Africa’s most important financial stories of the year landed on SENS. Sanlam (JSE: SLM), through its subsidiary Sanlam Life, made a formal offer to acquire all remaining Santam (JSE: SNT) shares it doesn’t already own.
The offer is R505 per share, a 26.6% premium to Friday’s closing price. The independent board unanimously recommended shareholders vote in favour. The deal, if approved, would see Santam delist from the JSE after 62 years ending a listed life that began in 1964.
Naturally, Santam jumped almost 19% on the news.
But here’s the thing I want you to think about today.
The Sanlam-Santam deal isn’t the only interesting part of this story.
The pattern behind it is.
Why Sanlam wants full control over Santam
Sanlam already owned 62.7% of Santam. It has controlled the business for years. The relationship between the two companies spans more than a century. Sanlam was literally established as a subsidiary of Santam to focus on life insurance, before the two went their separate ways and then came back together.
So why buy the remaining 37.3% now? And why pay R505 (above the all-time high) to do it?
Well, for Sanlam, this deal is about building a fortress position in South Africa. Simplifying governance. Eliminating the cost and complexity of maintaining a separately listed subsidiary. And freeing Santam from the constraints of having minority shareholders who need to be consulted on decisions that Sanlam is going to make anyway.
When a controlling shareholder decides to clean up the minority, it’s almost always for one of two reasons. Either the business is getting harder and they want full control of the cost-cutting, or the business is getting much more valuable and they don’t want to share the upside.
In Santam’s case, it’s clearly the second.
South Africa’s short-term insurance market is in the middle of a structural repricing cycle. The Hormuz crisis, the oil price spike and the diesel cost surge that MoneyMorning readers have been following for months are feeding directly into motor and commercial insurance claims costs, which are driving premium increases across the board. Santam, as South Africa’s largest short-term insurer, is positioned to capture that premium growth at scale.
Could this JSE small cap be another target for Sanlam?
Sanlam doesn’t just own Santam. It also holds a significant strategic stake in Afrocentric (JSE: ACT) – South Africa’s largest managed care organisation, administering medical scheme benefits for more than 4 million lives.
Afrocentric’s business model is the healthcare equivalent of what Santam represents in short-term insurance: a deeply embedded, contract-based, high-switching-cost operation that generates recurring revenue regardless of the economic cycle.
Moreover, it possesses other qualities that make a buyout attractive…
• A controlling shareholder
• Dominant listed subsidiary
• A gap between the listed price and the intrinsic value of a recurring, defensive, contract-based business
Of course there’s no guarantee. But the pattern is visible. And Sanlam CEO Paul Hanratty has been explicit about what his strategy is: build a fortress position in South Africa, simplify the structure, eliminate minority shareholders who complicate the governance of businesses Sanlam already controls operationally.
Afrocentric fits that description precisely.
What’s next?
For Santam shareholders, the R505 offer is real, it’s all cash, it’s above the all-time high and the independent board unanimously recommends it. The offer circular arrives around November 3. The premium is attractive. The main risk is regulatory approval timing, which could push the close into 2027. But there’s no obvious strategic reason for the deal to fail.
For everyone watching the JSE, Sanlam’s fortress-building strategy is one more data point in the broader delisting trend that is reshaping the South African equity market. Every major corporate that disappears from the JSE reduces the investable universe. Every take-private deal demonstrates the gap between listed prices and intrinsic values.
That gap between what the market thinks businesses are worth and what controlling shareholders are willing to pay to own them outright is the most important pricing anomaly on the JSE right now.
Not a subscriber to Money Morning?
You can get free daily recommendations like these with Money Morning eletter. Just sign up here.
